Metraipolis › archive › dc_cf03868fba40
hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer — Europe PMC PMID:40933893
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40933893
- DOI
- 10.3389/fonc.2025.1565244
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:38:57.355Z
- SHA-256 of the archived text
1e321fc361f0f7418a342680639122dd8846eb819994ee253e71dec0aa5b9fff- Stable URL of this page
https://metraipolis.com/documento/dc_cf03868fba40
How to cite
hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer — Europe PMC PMID:40933893 — Europe PMC (en), https://europepmc.org/article/MED/40933893 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf03868fba40 (Metraipolis archive dc_cf03868fba40, sha256 1e321fc361f0f7418a342680639122dd8846eb819994ee253e71dec0aa5b9fff)
BibTeX
@misc{dccf03868fba40,
title = {hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer — Europe PMC PMID:40933893},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40933893},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf03868fba40; sha256 1e321fc361f0f7418a342680639122dd8846eb819994ee253e71dec0aa5b9fff},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40933893. Agents can read the archived copy with the MCP tool read_document.